Agenda
Day 2 next page >
Day 1 - 30th April
- 09:30
- Introduction
Assembly Room - Dame Deidre Hine (Chair, Partners Forum, Wales Cancer Institute)
- 09:45
- Plenary Sessions
Assembly Room - Chair - Dame Deidre Hine (Chair, Partners Forum, Wales Cancer Institute)
Co-chair - Professor Tim Maughan (Consultant Clinical Oncologist, Velindre Hospital, Cardiff) - 09:45 - S001 - Drugging the cancer genome: Developments in novel therapies
- Professor Paul Workman (Professor of Pharmacology and Therapeutics, Institute of Cancer Research, Sutton)

- 10:15 - S002 - Communicating effectively with patients in oncology
- Professor Lesley Fallowfield (Professor of Psycho-Oncology and Director of Sussex Psychosocial Oncology Group Cancer Research UK, Brighton and Sussex Medical School, University of Sussex)
- 10:45 - 11:15
Refreshments - Lower Hall, Marble Hall- Parallel sessions
-
- 10:45 - 12:15
1) Cancer policy in Wales - Debate
Council Chamber
10:45 - S003 - Question and answer session with Key Welsh Assembly Members- Chair – Hywel Griffith (Health Correspondent, BBC Wales)
- Panel
- Helen Mary Jones AM (Plaid Cymru Spokesperson for Health)
- Jenny Randerson AM (Welsh Liberal Democrat Spokesperson for Health and Social Care)
- Val Lloyd AM (Labour Assembly Member for Swansea East)
- Cath Lindley (General Manager for Wales, Macmillan Cancer Support)
- Richard Davidson (Director of Policy and Public Affairs, Cancer Research UK)
- Glyn Davies (former Conservative Assembly Member and bowel cancer survivor)
Refreshments for attendees of this session will be available from 10:30 to 10:45 in the Annex Room
- 11:15 - 13:00
2) Basic science focus - bench to bedside
Syndicate Room D- Chair – Professor Raymond Waters (Associate Head of
Pathology, Department of Pathology, Cardiff University)
Co-chair – Professor Alan Clarke (Professor of Mammalian Genetics, Cardiff School of Biosciences, Cardiff University) - 11:20 - S004 - Human telomere dynamics and instability
- Dr Duncan Baird (Senior Research Fellow, Department of Pathology, Cardiff University)
- 11:45 - S005 - Colon cancer and Cox-2: new downstream targets and the importance of the tumour microenvironment for gene regulation
- Professor Chris Paraskeva (Professor of Experimental Oncology, Department of Cellular and Molecular Medicine, University of Bristol)
- 12:10 - S006 - Correcting the blueprint for life: determining the mechanism of global genome repair
- Dr Simon Reed (Senior Lecturer, Department of Pathology, Cardiff University)
- 12:35 - S007 - Using mouse models to identify potential novel therapeutic targets for colorectal cancer
- Professor Alan Clarke (Professor of Mammalian Genetics, Cardiff School of Biosciences, Cardiff University)
- 11:15 - 13:00
3) New therapies for cancer and their evaluation
in clinical trials
Assembly Room- Chair – Professor Alan Burnett (Head, Department of Haematology, Cardiff University)
Co-chair – Dr Andrew Westwell (Senior Lecturer in Medicinal Chemistry, Welsh School of Pharmacy, Cardiff University) - 11:20 - S008 - FLT3 inhibition in acute myeloid leukaemia
- Dr Steven Knapper (Clinical Senior Lecturer and Honorary Consultant Haematologist, Department of Haematology, Cardiff University)
- 11:40 - S009 - Aminopeptidase inhibition in haematological malignancies
- Dr Chris Jenkins (Department of Haematology, School of Medicine, Cardiff University)
- 12:00 - S010 - Targeting tumours from stem cells
- Professor Craig Jordan (Director of Haematologic Malignancies Translational Research Program, James P Wilmot Cancer Center, University of Rochester, New York)
- 12:20 - S011 - Designing kinase inhibitors based on structural information
- Dr Stefan Knapp (PI Biology, Structural Genomics Consortium, University of Oxford)
- 12:40 - S012 - Novel Assessment Techniques
- Dr Robert Hills (Senior Lecturer, Statistician, Department of Haematology, Cardiff University)
- 13:00
- Lunch and poster viewing - Lower Hall, Marble Hall
- Parallel sessions
-
- 14:30 - 16:30
4) Translational science focus – Bedside to Bench
Assembly Room- Chair – Professor Gerry Thomas (Professor of Molecular
Pathology, Department of Histopathology, Hammersmith Hospital, London)
Co-chair - Dr John Pritchard CBE (Vice Chairman, Cancer Research Wales) - 14:30 - S013 - PARP inhibition as a target therapy in a mouse model of Brca2 mutant breast cancer
- Dr Trevor Hay (Research Associate, Cardiff School of Biosciences, Cardiff University)
- 15:00 - S014 - OPCML - a new gene involved in women's cancer
- Professor Hani Gabra (Professor of Medical Oncology, Imperial College London)
- 15:30 - S015 - Wales Cancer Bank – current status and future prospects
- Professor Malcolm Mason (Head of Oncology Section, Department of Oncology and Palliative Medicine, Velindre Hospital, Cardiff)
- 16:00 - S016 - BAC array CGH profiles relating to activation of the ret oncogene
- Professor Horst Zitzelsberger (Leader of the Cytogenetics Group, Helmholtz Zentrum Munich, German Research Centre for Environmental Health, Munich Germany)
- 14:30 - 16:30
5) Clinical Trials Symposium
Syndicate Room C- Chair – Professor John Wagstaff (Director, Wales Cancer Trials Network)
Co-chair - Gareth Griffiths (Scientific Director, Wales Cancer Trials Unit) - 14:30 - Introduction
- Professor John Wagstaff (Director, Wales Cancer Trials Network, Swansea)
- 14:40 - Nano-medicines in oncology
- Professor Ruth Duncan (School of Pharmacy, Cardiff University)
- 15:05 - Discussion
- 15:10 - AML: where next – the AML17 Trial
- Professor Alan Burnett (Head, Department of Haematology, Cardiff University)
- 15:35 - Endocrine therapy trials in breast cancer: adjuvant and prevention
- Professor Tony Howell (CR UK Department of Medical Oncology, University of Manchester)
- 16:00 - Discussion
- 16:10 - The Wales Cancer Trials Unit: from idea to phase 3 trial
- Gareth Griffiths (Scientific Director, Wales Cancer Trials Unit, Cardiff)
- 16:25 - Summing up and final discussion
- Professor John Wagstaff (Director, Wales Cancer Trials Network, Swansea)
- 14:30 - 16:30
6) Survivorship – living with cancer
Syndicate Room D- Chair - Cath Lindley (General Manager for Wales, Macmillan Cancer Support)
- 14:35 - S018 - Living with cancer
- Professor Jessica Corner (Director of Improving Cancer Services, Macmillan Cancer Support)
- 14:50 - Contributions from the floor from people affected by cancer will be warmly welcome.
- 16:30 - 16:50
Refreshment Break - Lower hall, Marble Hall- 16:50
- Plenary session
Assembly Room - Chair – Dr Peter Barrett-Lee (Velindre Hospital, Cardiff)
Co-chair – Professor Robert Nicholson (Professor of Cancer Pharmacology, School of Pharmacy, Cardiff University) - 16:50 - Target therapy for breast cancer
- Dr Dennis Slamon (Director of Clinical and Translational Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles)
- 17:20 - S020 - Life after cancer treatment: A spectrum of chronic survivorship conditions
- Professor Jane Maher (National Clinical Lead NHS Improvement & Chief Medical Officer, Macmillan Cancer Support)
- 17:50
- Poster viewing and drinks reception
Lower hall -
- Poster judging panel
- Science
-
- Professor Julian Sampson - head judge (Head, Department of Medical Genetics, Cardiff University)
- Professor David Kipling (Professor of Pathology, Department of Pathology, Cardiff University)
- Dr Thomas Caspari (Director, North West Cancer Research Fund Institute, School of Biological Sciences, University of Wales, Bangor)
- Clinical
-
- Professor Roger Taylor (Professor in Oncology, South Wales Cancer Institute, Swansea)
- Professor Nick Stuart (Consultant Medical Oncologist, Gwynedd Hospital, Bangor)
- Professor Clare Wilkinson (Research Director, North Wales Clinical School, Cardiff University, Wrexham)
- 18:30
- Satellite symposium sponsored by Roche Products Limited
Syndicate Room D - Chair: Professor Tim Maughan (Consultant Clinical Oncologist, Velindre Hospital, Cardiff)
- Presentation on breast cancer
- Dr Dennis Slamon (Director of Clinical and Translational Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles)
- GI Presentation
- Dr Stephen Falk (Consultant Clinical Oncologist, The Bristol Haematology & Oncology Centre, Bristol)
- Presentation on lung cancer
- Professor Nikolas Thatcher (Christie Hospital NHS Trust, Manchester)
- Q and A Panel session
- 20:00
- Close of Satellite Symposium
- 20:30 -
midnight - Dinner and Ceilidh plus poster prize awarded - Assembly Room
- Professor Malcolm Mason – Master of Ceremonies






